Ancient embedded elements in our DNA from generations past can activate a powerful immune response to kill cancer cells like an infection.
news, journals and articles from all over the world.
Ancient embedded elements in our DNA from generations past can activate a powerful immune response to kill cancer cells like an infection.
While the world waits eagerly for a safe and effective vaccine to prevent infections from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus behind the COVID-19 pandemic, researchers also are focusing on better understanding how SARS-CoV-2 attacks the body in the search for other means of stopping its devastating impact. The key to one possibility — blocking a protein that enables the virus to turn the immune system against healthy cells — has been identified in a recent study by a team of Johns Hopkins Medicine researchers.
Researchers at Penn State College of Medicine now better understand the role of a protein, interleukin-21 (IL-21), in the immune system response to infections in the nervous system.
A Ludwig Cancer Research study has uncovered a mechanism by which the tumor’s harsh internal environment sabotages T lymphocytes, leading cellular agents of the anticancer immune response.
Gary Corbin, 63, dropped a heavy hurricane window shutter, which gashed his leg before it hit the ground. After wintering in Florida, this resident of Grosse Pointe Farms had been helping his significant other close down her Palm Beach Gardens home before they returned to Michigan in mid-June. He treated the wound and kept it covered on the drive north.
Researchers at UC San Diego School of Medicine report that the lasting nature of inflammatory bowel disease may be due to a type of long-lived immune cell that can provoke persistent, damaging inflammation in the intestinal tract.
Researchers investigating plant defenses—from threats spanning insects to pathogens—have discovered an “on-off” switch. The finding lays the groundwork for improved plant disease resistance and food stability.
A study by UCLA researchers shows that in people with mild cases of COVID-19, antibodies against SARS-CoV-2 — the virus that causes the disease — drop sharply over the first three months after infection, decreasing by roughly half every 73 days. If sustained at that rate, the antibodies would disappear within about a year.
Highlights In a recent study, genes were predicted to be expressed at different levels in the tissues of individuals with PTSD compared with those without PTSD. Individuals with PTSD tended to have a lower expression of a gene called SNRNP35…
UC San Diego Health has launched a Phase III clinical trial to assess whether a medication used to treat rheumatoid might also have therapeutic value for patient with COVID-19 who have developed or are at high risk of developing serious lung damage from SARS-CoV-2 infections.
By figuring out how a common virus hides from the immune system, scientists have identified a potential vaccine to prevent sometimes deadly respiratory infections in humans.
A new Penn Medicine study puts researchers within closer reach of vaccines that can protect infants against infections by overcoming a mother’s antibodies, which are known to shut down immune defenses initiated by conventional vaccines. That hurdle largely explains why vaccinations for infectious diseases like influenza and measles not given until six to 12 months of age. Findings from the preclinical study were published online today in Science Translational Medicine.